92 related articles for article (PubMed ID: 2832180)
1. Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow).
Shields JG; Smith SH; Strobel S; Levinsky RJ; Defrance T; De Vries J; Banchereau J; Callard RE
Eur J Immunol; 1988 Feb; 18(2):255-9. PubMed ID: 2832180
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
3. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
Rousset F; Billaud M; Blanchard D; Figdor C; Lenoir GM; Spits H; De Vries JE
J Immunol; 1989 Sep; 143(5):1490-8. PubMed ID: 2547869
[TBL] [Abstract][Full Text] [Related]
4. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte function-associated antigen (LFA-1) is involved in B cell activation.
Howard DR; Eaves AC; Takei F
J Immunol; 1986 Jun; 136(11):4013-8. PubMed ID: 2422269
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
7. Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1.
Krensky AM; Mentzer SJ; Clayberger C; Anderson DC; Schmalstieg FC; Burakoff SJ; Springer TA
J Immunol; 1985 Nov; 135(5):3102-8. PubMed ID: 3900204
[TBL] [Abstract][Full Text] [Related]
8. Role of the LFA-1 molecule in cellular interactions required for antibody production in humans.
Fischer A; Durandy A; Sterkers G; Griscelli C
J Immunol; 1986 May; 136(9):3198-203. PubMed ID: 3514755
[TBL] [Abstract][Full Text] [Related]
9. The LFA-1 antigen in human B lymphocyte activation.
Zola H; Furness V; Nikoloutsopoulos A; Neoh SH; Barclay S; Starr R; Day A; Russ GR
Dis Markers; 1989; 7(2):95-104. PubMed ID: 2659238
[TBL] [Abstract][Full Text] [Related]
10. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between B cell subpopulations defined by CD23 expression.
Armitage RJ; Goff LK
Eur J Immunol; 1988 Nov; 18(11):1753-60. PubMed ID: 2974422
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the role of leukocyte function-associated antigen-1 in activation of human influenza virus-specific T cell clones.
Kuijpers KC; Kuijpers TW; Zeijlemaker WP; Lucas CJ; van Lier RA; Miedema F
J Immunol; 1990 May; 144(9):3281-7. PubMed ID: 1970349
[TBL] [Abstract][Full Text] [Related]
13. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.
Smith SH; Rigley KP; Callard RE
Immunology; 1991 Jul; 73(3):293-7. PubMed ID: 1715315
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1).
Mishra GC; Berton MT; Oliver KG; Krammer PH; Uhr JW; Vitetta ES
J Immunol; 1986 Sep; 137(5):1590-8. PubMed ID: 3091687
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
16. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
[TBL] [Abstract][Full Text] [Related]
17. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
18. Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
Kikutani H; Nakamura H; Sato R; Kimura R; Yamasaki K; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4027-34. PubMed ID: 2422270
[TBL] [Abstract][Full Text] [Related]
19. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
20. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
